Paired liver–spleen high-frequency ultrasound deep learning network for full-stage liver fibrosis classification and clinical benefit compared with 2D-SWE in chronic hepatitis B cohort: a prospective multicenter study
- 23 December 2025
- journal article
- research article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 61 (2) , 184-194
Abstract
Background Elastography techniques such as two-dimensional shear wave elastography (2D-SWE) often result in missed or misdiagnoses when distinguishing between intermediate stages of liver fibrosis in clinical practice for patients with chronic hepatitis B (CHB). Methods Between January 2020 and August 2023, we prospectively enrolled 964 potentially eligible CHB patients from 6 hospitals who underwent liver biopsy. Finally, 598 patients with 2139 high-frequency ultrasound (HF-US) images were included. LS-Net, a deep learning network based on paired liver-spleen HF-US images was trained for distinguishing different stages of liver fibrosis against a comparison network(L-Net), 2D-SWE, and radiologist. We further simulated potential clinical utility across three clinical guidelines and conducted subgroup analyses for potential confounding factors. Results LS-Net demonstrated consistently superior performance for all-stage liver fibrosis classification in the validation set (AUROC: 0.94, 0.87, 0.92; p < 0.05) compared to L-Net, 2D-SWE, and radiologist assessment. In our clinical simulation focused on CHB patients, LS-Net reduced the biopsy rate to 9.9% for cirrhosis detection, increased essential referral by 40.3% for advanced fibrosis, and substantially improved treatment decision-making for significant fibrosis compared to 2D-SWE. The model maintained stable performance across subgroups (BMI, inflammation, ALT, antiviral status). Conclusions In this development and internal validation study in the CHB patient cohort, LS-Net demonstrated significantly higher diagnostic performance for all-stage liver fibrosis classification compared to L-Net, 2D-SWE and radiologist. Our findings indicate that LS-Net could offer potential clinical value for CHB management by reducing unnecessary biopsy rate, increasing essential referral rate, and promoting timely treatment.Keywords
Funding Information
- National Natural Science Foundation of China (No 82371977)
This publication has 29 references indexed in Scilit:
- The 2024 updated WHO guidelines for the prevention and management of chronic hepatitis B: Main changes and potential implications for the next major liver society clinical practice guidelinesJournal of Hepatology, 2024
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 updateJournal of Hepatology, 2021
- Medical Image Analysis using Convolutional Neural Networks: A ReviewJournal of Medical Systems, 2018
- New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatmentHepatology, 2016
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisJournal of Hepatology, 2015
- Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-analysis of Individual Participant DataClinical Gastroenterology and Hepatology, 2015
- The global burden of liver disease: The major impact of ChinaHepatology, 2014
- Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitisJournal of Hepatology, 2011
- Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosisJournal of Gastroenterology, 2003
- Classification of chronic viral hepatitis: a need for reassessmentJournal of Hepatology, 1991